XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Paid in Capital
Statutory Reserves
Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Total
Balance at at Dec. 31, 2018 $ 1,030 $ 114,493,283 $ 14,525,712 $ (4,620,930) $ (37,675,202) $ (3,544,624) $ 86,723,893
Balance at (in Shares) at Dec. 31, 2018 1,029,582            
Net loss for the quarter (1,942,294) (1,942,294)
Purchase of noncontrolling interest (3,948,242) 3,544,624 (3,948,242)
Issuance of common stock for equity financing $ 160 1,620,640 1,620,800
Issuance of common stock for equity financing (in Shares) 160,000            
Conversion of convertible notes including accrued interest into common shares $ 185 2,014,791 2,014,976
Conversion of convertible notes including accrued interest into common shares (in Shares) 185,195            
Transfer to statutory reserves 213,360 (213,360)
Foreign currency translation loss/gain 1,810,626 1,810,626
Balance at at Mar. 31, 2019 $ 1,375 114,180,472 14,739,072 (2,810,304) (39,830,856) 86,279,759
Balance at (in Shares) at Mar. 31, 2019 1,374,777            
Balance at at Dec. 31, 2019 $ 2,033 116,682,374 14,525,712 (6,132,614) (46,447,959)   78,629,546
Balance at (in Shares) at Dec. 31, 2019 2,032,721            
Net loss for the quarter (598,551)   (598,551)
Issuance of common stock for stock compensation $ 3 10,996   10,999
Issuance of common stock for stock compensation (in Shares) 3,333            
Conversion of long-term notes into common shares $ 143 533,024   533,167
Conversion of long-term notes into common shares (in Shares) 143,333            
Foreign currency translation loss/gain (1,341,276)   (1,341,276)
Balance at at Mar. 31, 2020 $ 2,179 $ 117,226,394 $ 14,525,712 $ (7,473,890) $ (47,046,510)   $ 77,233,885
Balance at (in Shares) at Mar. 31, 2020 2,179,387